CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study

NCT ID: NCT07181954

Last Updated: 2025-09-19

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 746 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2016-01-15
• Study Completion Date: 2023-12-31

Brief Summary

This project intends to construct a multicenter retrospective study, retrospectively collect clinical, imaging, pathological and prognostic data of patients, establish a complete data management system, establish a prediction model based on CT radiomics characteristics by combining radiomics, and verify the internal and external sequence of the model, which will improve the preoperative clinical diagnosis level of MIT family translocation kidney cancer, and then guide personalized and precise diagnosis and treatment.

Conditions

Renal Cell Carcinoma (RCC)

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Eligibility Criteria

Inclusion Criteria

1. Pathological diagnosis of RCC;

2. Have complete clinical, pathological and follow-up data;

3. Renal CT plain scan and enhanced images can be obtained from the image storage and transmission system (PACS)

Exclusion Criteria

1. Patients who are not suitable for treatment: patients with severe comorbidities or unable to receive any form of treatment;

2. Combined with other malignant tumors: have been treated with other malignant tumors (or have other untreated active malignancies at the same time);

3. Patients with poor CT image quality/absence;

4. Patients with missing clinical/pathological/follow-up data

• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

First Affiliated Hospital of Fujian Medical University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Other Identifiers

MRCTA, ECFAH of FMU [2025]794

Identifier Type: -

Identifier Source: org_study_id